Faricimab lacks proof of added benefit over comparator therapies for macular edema
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...
Tag: Ranibizumab
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...
